Hongzhou Lu
Infectious Diseases · 2020
A researcher in the Science corpus: 7 papers; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 66 citations into it; #287 of 589 by trust here, #71 by citations
Whom Hongzhou Lu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Hongzhou Lu overall
Papers from Hongzhou Lu's perspective
Ordered by how strongly the researchers Hongzhou Lu trusts endorse each paper. Same corpus, a different order for every researcher.
- Coronaviruses — drug discovery and therapeutic options (Nature reviews. Drug discovery)
- Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor (Nature)
- Bats Are Natural Reservoirs of SARS-Like Coronaviruses (Science)
- [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. (Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi)
- Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany (New England Journal of Medicine)
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. (Journal of the American Medical Association (JAMA))
- Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation
- Clinical Characteristics of Coronavirus Disease 2019 in China (Journal of Emergency Medicine)
- Report
- A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster (The Lancet)
Their papers
- Clinical progression of patients with COVID-19 in Shanghai, China (2020) — 763 citations
- Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia (2020) — 1,146 citations
- Drug treatment options for the 2019-new coronavirus (2019-nCoV). (2020) — 1,101 citations
- Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle (2020) — 3,118 citations
- Viral and host factors related to the clinical outcome of COVID-19 (2020) — 834 citations
- Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications (2020) — 832 citations
- COVID-19 with Different Severities: A Multicenter Study of Clinical Features (2020) — 775 citations